- Home
- SLRN vs TKNO Comparison
SLRN vs TKNO Comparison
Compare SLRN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- TKNO
- Stock Information
- Founded
- SLRN 2020
- TKNO 1996
- Country
- SLRN United States
- TKNO United States
- Employees
- SLRN N/A
- TKNO N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- SLRN Health Care
- TKNO Health Care
- Exchange
- SLRN Nasdaq
- TKNO Nasdaq
- Market Cap
- SLRN 485.6M
- TKNO 390.7M
- IPO Year
- SLRN 2023
- TKNO 2021
- Fundamental
- Price
- SLRN $3.15
- TKNO $7.73
- Analyst Decision
- SLRN Buy
- TKNO Buy
- Analyst Count
- SLRN 4
- TKNO 2
- Target Price
- SLRN $11.75
- TKNO $5.00
- AVG Volume (30 Days)
- SLRN 811.9K
- TKNO 206.5K
- Earning Date
- SLRN 11-13-2024
- TKNO 11-07-2024
- Dividend Yield
- SLRN N/A
- TKNO N/A
- EPS Growth
- SLRN N/A
- TKNO N/A
- EPS
- SLRN N/A
- TKNO N/A
- Revenue
- SLRN N/A
- TKNO $36,347,000.00
- Revenue This Year
- SLRN N/A
- TKNO $3.47
- Revenue Next Year
- SLRN N/A
- TKNO $12.07
- P/E Ratio
- SLRN N/A
- TKNO N/A
- Revenue Growth
- SLRN N/A
- TKNO N/A
- 52 Week Low
- SLRN $3.11
- TKNO $1.16
- 52 Week High
- SLRN $8.89
- TKNO $8.91
- Technical
- Relative Strength Index (RSI)
- SLRN 26.85
- TKNO 51.60
- Support Level
- SLRN $3.11
- TKNO $7.00
- Resistance Level
- SLRN $3.60
- TKNO $8.89
- Average True Range (ATR)
- SLRN 0.29
- TKNO 0.74
- MACD
- SLRN -0.05
- TKNO -0.09
- Stochastic Oscillator
- SLRN 1.48
- TKNO 38.24
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.